Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Population groups
  • Active substance : rifampicine
  • Active substance : josamycine
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Respiratory tract diseases (1)
    • Plus ...
      • Pulmonary and pleural diseases (1)
      • Bronchial diseases (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Manufacturer
  • industriels (1)
Language
  • Français (1)
Active substance
  • alcool (1)
  • allopurinol (1)
  • aminophylline (1)
  • aspirine (1)
  • carbachol (1)
  • ciprofloxacine (1)
  • clarithromycine (1)
  • fluconazole (1)
  • flunisolide (1)
  • halothane (1)
  • iode (1)
  • itraconazole (1)
  • josamycine (1)
  • lopinavir (1)
  • mannitol (1)
  • norfloxacine (1)
  • pentoxifylline (1)
  • prednisolone (1)
  • prednisone (1)
  • primidone (1)
  • propionate de fluticasone (1)
  • rifabutine (1)
  • rifampicine (1)
  • ritonavir (1)
  • roxithromycine (1)
  • salbutamol (1)
  • stiripentol (1)

Practice guidelines and other guides - 1 result

  • Medical follow-up of patients with asthma - Adults and adolescents

    Practice guidelines - Posted on 1/9/2004
    Download abstract
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
dk3aPZYCK5W3Z3jn